In this presentation, Anand A. Patel, MD, reviewed the contemporary standard-of-care treatment roadmap for AML in 2025, covering key phases like induction chemotherapy (eg, the “7+3” regimen), consolidation…
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York, discusses the treatment strategies for patients who develop secondary acute myeloid leukemia (AML) following hypomethylating agent…
This nano-sensor array might be able to smell cancer, Parkinson's, and other conditions by analyzing your breath, even before your doctor could detect them by other means.
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
The U.S. Preventive Services Task Force (USPSTF) recently reversed its position that annual skin screenings are recommended for all adults, citing that the “current evidence is insufficient and…
Many cancer patients are not geographically-situated near the cancer care centers that offer them the best chances of recovery or survival. This is one of the many reasons…
Active surveillance of low- and mid-risk prostate cancer is becoming a widely accepted alternative to quickly administering more aggressive forms of therapy upon diagnosis. Educating patients on the…
Epstein-Barr virus (EBV), similar to other common viruses, remains in the body indefinitely after exposure and requires constant monitoring by the immune system in order to effectively to…
Precision medicine aims to tailor medical treatments to each patient’s individual genetic profile and biology. Cancer researchers know that patients with particular mutations may respond better to certain…
